Founded in 2015 after a conversation about improving existing drugs with nanotechnology, LeadInvent Pharma develops localized, laser-activated treatments for brain cancer. Its lead product, GBGel™, grew from collaboration with Amrita Nano Science Centre and neuro-oncology experts and is designed to target residual tumor cells after surgery while limiting systemic exposure. The team brings more than 350 man-years of drug-development and pharmaceutical-science experience to moving the technology from laboratory research toward clinical use.
Tactical TherapeuticsFounded in 2005 by cancer scientist and patent attorney Rashida A. Karmali, Tactical Therapeutics is a clinical-stage biopharmaceutical company built around her long career in cancer research, drug development, and intellectual property law. The company develops CTO, an oral therapy designed to reach the brain, for patients with glioblastoma and other cancers that have resisted treatment. Karmali has authored more than 100 scientific publications and holds eight U.S. patents alongside more than 75 international patents.NEW YORK, NY
Zetagen TherapeuticsFounded in 2015, Zetagen Therapeutics is a private, clinical-stage biopharmaceutical company built around a patient-centered approach to cancer research. From its Colleen Connor Cancer Research Lab, the company develops local treatments for people with metastatic cancer affecting bone, including the investigational therapy ZetaMet, which is designed to address tumors while supporting bone repair.SYRACUSE, NY
NovocureNovocure grew from Professor Yoram Palti’s basement laboratory in Haifa, where he began exploring electric fields as a way to target cancer cells in 2000. Today, the international oncology company develops and commercializes Tumor Treating Fields therapy for patients facing some of the most aggressive solid tumors, while continuing research into wider applications.WAYNE, PA
Nanobrid Innovations Private LimitedNanobrid Innovations Private Limited is an Indian nanotechnology company developing formulation solutions for drug delivery. Its proprietary Nanobrid® platform is intended to help deliver difficult-to-formulate active ingredients more effectively and conveniently for patients.RAJASTHAN, IN